Decreased anterior cingulate myo-inositol/creatine spectroscopy resonance with lithium treatment in children with bipolar disorder

被引:161
|
作者
Davanzo, P
Thomas, MA
Yue, K
Oshiro, T
Belin, T
Strober, M
McCracken, J
机构
[1] Univ Calif Los Angeles, Dept Psychiat & Behav Sci, Sch Med, Los Angeles, CA 90024 USA
[2] Univ Calif Los Angeles, Sch Med, Dept Radiol Sci, Los Angeles, CA 90024 USA
[3] Univ Calif Los Angeles, Sch Med, Dept Biostat, Los Angeles, CA 90024 USA
关键词
pre-adolescents; mania; hypomania; lithium; magnetic resonance spectroscopy;
D O I
10.1016/S0893-133X(00)00207-4
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
This project was designed to compare differences in brain proton spectra between children and adolescents with bipolar disorder (BPD) and gender and age-matched normal controls, and to measure changes in myo-inositol levels following lithium therapy, utilizing in vivo proton magnetic resonance spectroscopy (H-1 MRS). A single voxel (2X2X2 cm3) was placed in brain anterior cingulate cortex for acquisition of the H-1 spectra at baseline and after acute (similar to 7days) lithium administration in 11 children (mean age 11.4 years) diagnosed with BPD, and in 11 normal controls. Acute lithium treatment was associated with a significant reduction in the myo-inositol/creatine ratio. This decrement was also significant in lithium-responders when analyzed seperate from non-responders. Compared to normal controls, BPD subjects showed a trend towards a higher myo-inositol/creatine during the manic phase. These preliminary data provide evidence that a significant reduction in anterior cingulate myo-insolitol magnetic resonance may occur after lithium treatment, especially among responders. Follow-up studies involving a larger sample may allow us to confirm whether changes in myoinositol associated with acute lithium therapy persist in long-term clinical response of patients with and without lithium compliance. (C) 2001 American College of Neuropsychopharmacology. Published by Elsevier Science Inc.
引用
收藏
页码:359 / 369
页数:11
相关论文
共 50 条
  • [41] Identification of lithium mimetic that inhibits inositol monophosphatase for the treatment of bipolar disorder
    Singh, N.
    Vasudevan, S. R.
    Thomas, J. M.
    Knight, M.
    Sharp, T.
    Churchill, G. C.
    BIPOLAR DISORDERS, 2011, 13 : 90 - 90
  • [42] Neurochemical alterations in anterior cingulate cortex in bipolar disorder: a proton magnetic resonance spectroscopy study (1H-MRS)
    Galinska-Skok, Beata
    Konarzewska, Beata
    Kubas, Bozena
    Tarasow, Eugeniusz
    Szulc, Agata
    PSYCHIATRIA POLSKA, 2016, 50 (04) : 839 - 848
  • [43] Association between genetic variation in the myo-inositol monophosphatase 2 (IMPA2) gene and age at onset of bipolar disorder
    Tomioka, Yoko
    Jimenez, Esther
    Salagre, Estela
    Arias, Barbara
    Mitjans, Marina
    Ruiz, Victoria
    Saiz, Pilar
    Paz Garcia-Portilla, Maria
    de la Fuente, Lorena
    Patricia Gomes-da-Costa, Susana
    Bobes, Julio
    Vieta, Eduard
    Benabarre, Antoni
    Grande, Iria
    JOURNAL OF AFFECTIVE DISORDERS, 2018, 232 : 229 - 236
  • [44] Crystal structure of human myo-inositol monophosphatase 2, the product of the putative susceptibility gene for bipolar disorder, schizophrenia, and febrile seizures
    Arai, Ryoichi
    Ito, Kaori
    Ohnishi, Tetsuo
    Ohba, Hisako
    Akasaka, Ryogo
    Bessho, Yoshitaka
    Hanawa-Suetsugu, Kyoko
    Yoshikawa, Takeo
    Shirouzu, Mikako
    Yokoyama, Shigeyuki
    PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS, 2007, 67 (03) : 732 - 742
  • [45] Brain myo-inositol level is elevated in Ts65Dn mouse and reduced after lithium treatment
    Huang, W
    Galdzicki, Z
    van Gelderen, P
    Balbo, A
    Chikhale, EG
    Schapiro, MB
    Rapoport, SI
    NEUROREPORT, 2000, 11 (03) : 445 - 448
  • [46] Association between a 2030-G/A substitution in the human myo-inositol monophosphatase gene (IMPA) and bipolar disorder and schizophrenia.
    Birkett, JTP
    Kirov, G
    Arranz, MJ
    Murray, RM
    Collier, DA
    Kerwin, RW
    MOLECULAR PSYCHIATRY, 1999, 4 : S103 - S103
  • [47] Brain MYO-inositol concentrations are not altered in bipolar disorder patients receiving sodium valproate: An in vivo proton MRS quantitative study
    Wu, RH
    Silverstone, PH
    Lang, ZJ
    RADIOLOGY, 2002, 225 : 611 - 611
  • [48] Myo-inositol in depressive and healthy subjects determined by frontal 1H-magnetic resonance spectroscopy at 1.5 tesla
    Frey, R
    Metzler, D
    Fischer, P
    Heiden, A
    Scharfetter, J
    Moser, E
    Kasper, S
    JOURNAL OF PSYCHIATRIC RESEARCH, 1998, 32 (06) : 411 - 420
  • [49] Proton magnetic resonance spectroscopy in 22q11 deletion syndrome : Evidence for glutamate and myo-Inositol dysfunction
    Alves, F. Da Silva
    Boot, E.
    Schmitz, N.
    Nederveen, A.
    Lavini, C.
    Vorstman, J.
    Pouwels, P.
    Linszen, D.
    van Amelsvoort, T.
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2010, 13 : 175 - 175
  • [50] Myo-Inositol Levels Measured with MR Spectroscopy Can Help Predict Failure of Antiangiogenic Treatment in Recurrent Glioblastoma
    El-Abtah, Mohamed E.
    Wenke, Michael R.
    Talati, Pratik
    Fu, Melanie
    Kim, Daniel
    Weerasekera, Akila
    He, Julian
    Vaynrub, Anna
    Vangel, Mark
    Rapalino, Otto
    Andronesi, Ovidiu
    Arrillaga-Romany, Isabel
    Forst, Deborah A.
    Yen, Yi-Fen
    Rosen, Bruce
    Batchelor, Tracy T.
    Gonzalez, R. Gilberto
    Dietrich, Jorg
    Gerstner, Elizabeth R.
    Ratai, Eva-Maria
    RADIOLOGY, 2022, 302 (02) : 410 - 418